Urgent Call for Co-Pay Caps for Type 1 Diabetes Treatments in Utah
Diagnosed with Type 1 diabetes in the hospital, the need for affordable insulin is urgent.

Last August, I was admitted to a hospital with a dangerously high blood sugar level of 550. After a brief examination, the attending doctor diagnosed me with Type 1 diabetes. The diagnosis was a shock, but the medical team acted promptly, and I was informed that my first insulin infusion would commence as soon as the nurse arrived. Type 1 diabetes is a chronic condition that requires continuous management and care. It affects the body's ability to produce insulin, leading to high blood sugar levels if left untreated. For many patients, including myself, this means regular monitoring and insulin administration to maintain blood glucose levels. The costs associated with managing Type 1 diabetes can be substantial. Patients often face high co-pays for insulin and other essential medications. These expenses can accumulate, making it difficult for individuals and families to manage their financial responsibilities while ensuring they receive necessary medical care. The rising costs of diabetes management have become a pressing issue for many patients. Access to affordable insulin is crucial for effective disease management, yet many patients find themselves struggling to afford their medications. Advocacy for co-pay caps on insulin and diabetes supplies is gaining momentum as more patients share their stories of financial hardship. Health professionals and patient advocates are calling for legislative measures to ensure that insulin and other diabetes-related medications are accessible and affordable. In Utah, there is a growing awareness of the need for these changes. Legislative discussions are underway regarding potential policies aimed at curbing the costs associated with diabetes care. Ensuring that patients have access to affordable treatment is essential for their health and well-being. With Type 1 diabetes affecting a significant number of individuals, the need for co-pay caps and affordable medication options is more urgent than ever. It is essential that we address these challenges to improve the quality of life for those living with this condition.





